Parkinson's disease is a chronic progressive neurological disease that affects nerve cells (neurons) in an area of the brain known as the substantia nigra. When healthy these cells normally produce dopamine, a chemical (neurotransmitter) which transmits signals between areas in the brain. This chemical coordinates smooth and balanced muscle movement. Parkinson's disease causes these nerve cells to die, and as a result, body movements are affected.
Today, new treatments and advances in research are giving new hope to people affected by this disease. The Parkinson’s Stem Cell Clinical Trials are being studied for their efficacy in improving the complications in patients with Alzheimer’s, through the use of stem cells. These procedures may help patients who don't respond to typical drug treatment.
To learn more about StemGenex clinical trials for Parkinson’s simply fill out the form below and a StemGenex Patient Advocate will contact you shortly.
Fields marked with an asterisk (*) are required.
Question IDs
Object Type Map
Visibility Map
Active Map
Validator Map
Children Map
Parent Map
Question Options Map
Question Options
Question Option Activate Map